Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rubenstein

Showing results (271-280 of 477) with videos related to

Pageof 48
Sort By:
Endocrinology|December 1, 1983
The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedureO D Madsen, R M Cohen, F W Fitch, et al.
The New England Journal of Medicine|May 31, 1973
Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivityM B Block, R L Rosenfield, M E Mako, et al.
JAMA Dermatology|June 9, 2016
Unilateral Gottron Papules in a Patient Following a Stroke: Clinical Insights Into the Disease Mechanisms and Pathophysiology of Cutaneous DermatomyositisDrew J B Kurtzman, Allen Ho, Natalie A Wright, et al.
Diabetologia|October 1, 1976
Clinical correlations of serum proinsulin-like material in islet cell tumoursR N Alsever, M R Stjernholm, K E Sussman, et al.
Journal of Chromatography. A|December 28, 2020
Improving Quantification of tabun, sarin, soman, cyclosarin, and sulfur mustard by focusing agents: A field portable gas chromatography-mass spectrometry studyJohn T Kelly, Anthony Qualley, Geoffrey T Hughes, et al.
Diabetologia|November 1, 1980
Antibodies direct against the pancreatic islet cell plasma membrane. Detection and specificityA Lernmark, T Kanatsuna, C Patzelt, et al.
Annals of Hematology|March 23, 2001
A case of pulmonary toxicity associated with G-CSF and doxorubicin administrationC F Eisenbeis, D Winn, S Poelman, et al.
Circulation|January 11, 2000
Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?M H Rubenstein, L C Harrell, B V Sheynberg, et al.
Endocrinology|November 1, 1990
Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolitesH Tillil, B H Frank, A H Pekar, et al.
Diabetes Care|June 1, 1990
Lessons learned from molecular biology of insulin-gene mutationsD F Steiner, H S Tager, S J Chan, et al.
Pageof 48

Showing results (271-280 of 477) with videos related to

Sort By:
Pageof 48
Endocrinology|December 1, 1983
The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedureO D Madsen, R M Cohen, F W Fitch, et al.
The New England Journal of Medicine|May 31, 1973
Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivityM B Block, R L Rosenfield, M E Mako, et al.
JAMA Dermatology|June 9, 2016
Unilateral Gottron Papules in a Patient Following a Stroke: Clinical Insights Into the Disease Mechanisms and Pathophysiology of Cutaneous DermatomyositisDrew J B Kurtzman, Allen Ho, Natalie A Wright, et al.
Diabetologia|October 1, 1976
Clinical correlations of serum proinsulin-like material in islet cell tumoursR N Alsever, M R Stjernholm, K E Sussman, et al.
Journal of Chromatography. A|December 28, 2020
Improving Quantification of tabun, sarin, soman, cyclosarin, and sulfur mustard by focusing agents: A field portable gas chromatography-mass spectrometry studyJohn T Kelly, Anthony Qualley, Geoffrey T Hughes, et al.
Diabetologia|November 1, 1980
Antibodies direct against the pancreatic islet cell plasma membrane. Detection and specificityA Lernmark, T Kanatsuna, C Patzelt, et al.
Annals of Hematology|March 23, 2001
A case of pulmonary toxicity associated with G-CSF and doxorubicin administrationC F Eisenbeis, D Winn, S Poelman, et al.
Circulation|January 11, 2000
Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?M H Rubenstein, L C Harrell, B V Sheynberg, et al.
Endocrinology|November 1, 1990
Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolitesH Tillil, B H Frank, A H Pekar, et al.
Diabetes Care|June 1, 1990
Lessons learned from molecular biology of insulin-gene mutationsD F Steiner, H S Tager, S J Chan, et al.
Pageof 48